News

Prostaglandin analogs were associated with a lower risk for uveitis compared with other topical glaucoma medications, ...
Pfizer halted its oral obesity drug, danuglipron, in April 2025 due to liver injury concerns, a major pipeline setback. Find ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
Learn which drugs can cause dry eye disease, and what to do if you’re taking a medication that can cause dry eye symptoms.
Despite her active and healthy lifestyle, Sasha Barden felt stuck in her weight loss journey. She decided to try GLP-1 medications to support her weight loss goal. After six months on Wegovy ...
GLP-1 agonists may help reduce acetazolamide dosage in patients with idiopathic intracranial hypertension without changing clinical outcome.
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...
Eli Lilly’s acquisition of SiteOne Therapeutics comes ahead of Phase 2 testing of the startup’s lead drug candidate, which ...
A research team has unveiled the cause and molecular mechanism of chronic brain inflammation that results in repetitive ...
“Fructo-oligosaccharides (FOS) are prebiotic fibers that have a significant impact on the secretion and function of the ...